Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Endocrinol.

Sec. Pediatric Endocrinology

Correction: Determinants of adverse event occurrence in children with short stature born small for gestational age treated with growth hormone

Provisionally accepted
Regis  CoutantRegis Coutant1*Nazim  BenchikhNazim Benchikh2Agnes  LinglartAgnes Linglart3Marc  NicolinoMarc Nicolino4Jean-Pierre  SallesJean-Pierre Salles5
  • 1Centre Hospitalier Universitaire d'Angers, Angers, France
  • 2Novo Nordisk, Paris, France
  • 3AP-HP, Paris Saclay University, INSERM, Physiologie et Physiopathologie Endocriniennes, Endocrinology and Diabetology for Children, Bicêtre Paris Saclay Hospital, Le Kremlin-Bicetre, France
  • 4Lyon University Pediatric Hospital, Lyon, France
  • 5Endocrinology and Bone Diseases Unit, Children’s Hospital, Toulouse University Hospital, University of Toulouse Paul Sabatier, INSERM-CNRS Unit 1291, Infinity Center, Toulouse, France

The final, formatted version of the article will be published soon.

A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval. • Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others.• Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used.The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.

Keywords: Growth Hormone, Small for Gestational age (SGA), Adverse event (AE), Serious adverse event (SAE), Real world data (RWD)

Received: 25 Nov 2025; Accepted: 28 Nov 2025.

Copyright: © 2025 Coutant, Benchikh, Linglart, Nicolino and Salles. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Regis Coutant

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.